查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654726

全球光疗设备市场 - 2025 至 2033 年

Global Phototherapy Equipment Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球光疗设备市场规模达到 5.2121 亿美元，预计到 2033 年将达到 7.4652 亿美元，2025-2033 年预测期内的复合年增长率为 4.8%。

全球光疗设备市场包括使用特定波长的光来治疗各种皮肤状况和疾病的设备和系统。这种医疗方法通常称为光疗法或光疗，可有效治疗多种疾病，包括牛皮癣、湿疹和白斑症。

牛皮癣是一种慢性自体免疫疾病，其特征是皮肤细胞快速增殖，导致出现厚、红、鳞状斑块。光疗法透过将皮肤暴露在紫外线 (UV) 下来帮助控制这种情况，这可以减缓过多的皮肤细胞生成并减少发炎。湿疹，或称为异位性皮肤炎，是一种常见的发炎性皮肤病，导致皮肤发红、发痒和发炎。光疗法可以减轻发炎和瘙痒，对湿疹患者有益。

白斑症是一种皮肤病，其特征是黑色素细胞被破坏导致斑块中色素脱落。光疗法，尤其是窄频 UVB 疗法，可以刺激患处的色素重新沉淀。新生儿黄疸是新生儿常见的疾病，由血液中胆红素过多引起，导致皮肤和眼睛发黄。光疗法是这种病症的标准治疗方法；该方法包括将婴儿置于专门的蓝光下，帮助分解皮肤中的胆红素，促进其排泄。

由于人们对这些情况的认识不断提高和光疗技术的进步，全球光疗设备市场正在经历显着增长。基于 LED 的系统和光纤设备等设备由于其有效性和安全性而变得越来越普遍。这些因素推动了全球光疗设备市场的扩张。

市场动态：

驱动因素与约束因素

光疗技术的创新

目前，全球光疗设备市场正见证光疗技术创新所推动的重大进步。这些进步正在提高治疗效果、病人安全性以及光疗解决方案的整体可近性。

转向基于 LED 的光疗设备是市场的重要趋势。 LED 具有高效率、高耐用性，并且能够发射治疗各种皮肤病所需的特定波长的光。与传统萤光灯相比，它们的维护需求低且能耗低，可提高治疗效果，同时降低医疗服务提供者的营运成本。

家庭医疗保健的兴起刺激了患者可在家中使用的便携式光疗设备的发展。这种趋势对于新生儿黄疸和慢性皮肤病等需要持续治疗的疾病尤其重要。家庭护理解决方案提供了便利，减少了去医院的频率，并使患者能够更有效地管理自己的病情。

此外，业界主要参与者推出的创新产品将推动全球光疗设备市场的成长。这些设备利用红光和近红外光疗法提供广泛的健康益处，使不同群体都能使用。

此外，2024 年 6 月，Dermalux 在伦敦科文特花园 IceTank 举行的发表会上推出了创新 LED 光疗治疗系统 Tri-Wave MD MK II。这款先进的设备经过专门设计，可为大面积皮肤提供有效的光疗，适合各种皮肤状况。所有这些因素都要求全球光疗设备市场的发展。

此外，对智慧技术整合的需求不断增长，促进了全球光疗设备市场的扩张。

与治疗相关的风险因素

与 UVB 和 PUVA 疗法相关的併发症对全球光疗设备市场造成了重大限制，因为它们会对患者安全和治疗接受度产生不利影响。根据美国国家生物技术资讯中心 (NCBI) 2024 年 2 月的资料，UVB 疗法的急性影响包括红斑和灼热感，通常在 12 至 24 小时内达到峰值，并且对于皮肤类型较白或服用某些药物的人来说可能更为严重。

慢性併发症可导致光老化，其特征是皮肤干燥、起皱和皮肤脆弱性增加，同时宽频和窄带 UVB 疗法之间具有不同的潜在致癌风险。 PUVA 疗法还具有光毒性等急性风险，导致长时间的红斑、噁心和罕见的指甲损伤，而慢性影响可能包括 PUVA 雀斑、鳞状细胞癌风险增加以及由于补骨脂素在眼晶状体中积聚而可能导致白内障发展。因此，上述因素可能会限制全球光疗设备市场的潜在成长。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动态

  • 影响因素
    • 驱动程式
      • 光疗技术的创新
    • 限制
      • 与治疗相关的风险因素
    • 机会
    • 影响分析

第五章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 6 章：依产品类型

  • 常规光疗设备
    • 全身光疗设备
    • 局部身体光疗设备
    • 常规萤光灯光疗设备
    • 配有紧凑型萤光灯的传统光疗设备
  • LED光疗设备
  • 光纤光疗设备
  • 杀菌灯
  • 配件

第 7 章：按辐射类型

  • UVA（紫外线A
  • UVB（紫外线B）
  • UVC（紫外线C）

第 8 章：按应用

  • 皮肤病治疗
    • 牛皮癣
    • 湿疹
    • 白斑
    • 粉刺
    • 其他的
  • 新生儿黄疸管理

第 9 章：按最终用户

  • 医院及专科诊所
  • 皮肤科中心
  • 其他的

第 10 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • GE Healthcare
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • Philips
  • Natus Medical Incorporated
  • Phoenix Medical Systems.
  • Atom Medical Corp.
  • Nice Neotech Medical Systems Pvt. Ltd.
  • NatBio.
  • Solarc Systems Inc.
  • The Daavlin Company
  • MTTS.

第 13 章：附录

简介目录
Product Code: MD1626

The global phototherapy equipment market reached US$ 521.21 million in 2024 and is expected to reach US$ 746.52 million by 2033, growing at a CAGR of 4.8 % during the forecast period 2025-2033.

The global phototherapy equipment market includes devices and systems that use specific wavelengths of light to treat various skin conditions and disorders. This medical treatment, commonly known as phototherapy or light therapy, effectively addresses a range of conditions, including psoriasis, eczema, and vitiligo.

Psoriasis is a chronic autoimmune disease characterized by the rapid proliferation of skin cells, resulting in thick, red, and scaly patches. Phototherapy helps manage this condition by exposing the skin to ultraviolet (UV) light, which can slow down the excessive skin cell production and reduce inflammation. Eczema, or atopic dermatitis, is a prevalent inflammatory skin condition that leads to red, itchy, and inflamed skin. Phototherapy can be beneficial for individuals with eczema by reducing inflammation and itching.

Vitiligo is a skin disorder marked by the loss of pigment in patches due to the destruction of melanocytes. Phototherapy, particularly narrowband UVB therapy, can stimulate repigmentation in affected areas. Neonatal jaundice is a common condition in newborns caused by an excess of bilirubin in the blood, leading to yellowing of the skin and eyes. Phototherapy is a standard treatment for this condition; it involves placing the infant under specialized blue lights that help break down bilirubin in the skin, facilitating its excretion.

The global phototherapy equipment market is witnessing significant growth due to increasing awareness of these conditions and advancements in phototherapy technology. Devices such as LED-based systems and fiber-optic equipment are becoming more prevalent due to their effectiveness and safety features. These factors have driven the global phototherapy equipment market expansion.

Market Dynamics: Drivers & Restraints

Innovations in Phototherapy Technology

The global phototherapy equipment market is currently witnessing substantial advancements propelled by innovations in phototherapy technology. These advancements are improving treatment effectiveness, patient safety, and overall accessibility to phototherapy solutions.

The shift towards LED-based phototherapy devices is a significant trend in the market. LEDs offer high efficiency, durability, and the capability to emit specific wavelengths of light necessary for treating various skin conditions. Their low maintenance needs and reduced energy consumption make them preferable over traditional fluorescent lamps, enhancing treatment outcomes while lowering operational costs for healthcare providers.

The rise in home healthcare has spurred the development of portable phototherapy devices that patients can use at home. This trend is particularly relevant for conditions like neonatal jaundice and chronic skin disorders, where continuous treatment is essential. Homecare solutions provide convenience, reduce the frequency of hospital visits, and empower patients to manage their conditions more effectively.

Furthermore, key players in the industry innovative product launches that would drive this global phototherapy equipment market growth.For instance, in April 2024, Bestqool launched a new line of portable red light therapy devices, specifically engineered for effective and convenient use at home. These devices utilize red and near-infrared light therapy to offer a wide range of health benefits, making them accessible to a diverse audience.

Also, in June 2024, Dermalux introduced the Tri-Wave MD MK II, an innovative LED phototherapy treatment system, during a launch event held at IceTank in Covent Garden, London. This advanced device is specifically engineered to deliver effective light therapy over extensive skin areas, making it suitable for a variety of skin conditions. All these factors demand the global phototherapy equipment market.

Moreover, the rising demand for the integration of smart technologies contributes to the global phototherapy equipment market expansion.

Risk Factors Associated with the Treatment

The complications associated with UVB and PUVA therapy present significant restraints in the Global Phototherapy Equipment Market, as they can adversely affect patient safety and treatment acceptance. According to the National Center for Biotechnology Information (NCBI) data in February 2024, acute effects of UVB therapy include erythema and burning sensations, which typically peak within 12 to 24 hours and may be more severe in individuals with lighter skin types or those on certain medications.

Chronic complications can lead to photoaging, characterized by dry skin, wrinkling, and increased skin fragility, alongside potential carcinogenic risks that differ between broadband and narrowband UVB therapies. PUVA therapy also carries acute risks such as phototoxicity, resulting in prolonged erythema, nausea, and rare nail damage, while chronic effects may include PUVA lentigines, an elevated risk of squamous cell carcinoma, and potential cataract development due to psoralen accumulation in the ocular lens. Thus, the above factors could be limiting the global phototherapy equipment market's potential growth.

Segment Analysis

The global phototherapy equipment market is segmented based on product type, radiation type, application, end-user, and region.

Product Type:

The conventional phototherapy equipment segment is expected to dominate the global phototherapy equipment market share

The conventional phototherapy equipment segment holds a major portion of the global phototherapy equipment market share and is expected to continue to hold a significant portion of the global phototherapy equipment market share during the forecast period.

The global phototherapy equipment market includes a diverse range of devices specifically designed for the effective treatment of skin conditions and neonatal jaundice. A significant segment within this market is conventional phototherapy equipment, which can be categorized into several types, including full-body phototherapy equipment, partial-body phototherapy equipment, conventional phototherapy equipment with fluorescent lamps, and conventional phototherapy equipment with compact fluorescent lamps.

Conventional phototherapy equipment primarily utilizes light sources such as fluorescent lamps and compact fluorescent lamps to deliver therapeutic light. These devices are widely utilized in clinical settings due to their proven effectiveness and affordability in treating conditions like psoriasis, eczema, vitiligo, and neonatal jaundice. Their established presence in healthcare facilities highlights their importance in dermatological care.

Conventional phototherapy equipment includes full-body phototherapy equipment, partial-body phototherapy equipment, conventional phototherapy equipment with fluorescent lamps, and conventional phototherapy equipment with compact fluorescent lamps. Full-body phototherapy units are designed to expose the entire body to therapeutic light, making them particularly effective for treating extensive skin conditions or managing neonatal jaundice in infants. Partial-body phototherapy equipment is tailored for localized treatment of specific areas affected by skin conditions.

Conventional phototherapy equipment with fluorescent lamps this category includes devices that utilize traditional fluorescent lamps as their primary light source. Compact fluorescent lamps (CFLs) represent a modern advancement within the conventional phototherapy segment. CFLs are smaller and more energy efficient than traditional fluorescent tubes while producing higher irradiance levels.

Furthermore, key players in the industry have key initiatives and innovative product launches that would propel this segment's growth in the global phototherapy equipment market. For instance, in September 2024, Best Choice Specialist Hospital unveiled the first intensive infant phototherapy machine in Kano, Nigeria. This cutting-edge equipment is specifically designed to effectively treat jaundice in newborns, representing a significant advancement in neonatal care for the region. The introduction of this machine aims to enhance healthcare solutions for infants suffering from jaundice, improving treatment capabilities at the hospital and providing families with better access to essential medical care.

Also, in November 2023, GlobalMed Technologies introduced the Omnilux Mini, a new line of three FDA-cleared LED devices designed for targeted skincare treatments. Each device is distinguished by its flexibility, portability, and affordability, retailing at $95. The Omnilux Mini utilizes red, near-infrared, and blue LEDs to effectively tackle various skin issues, including fine lines, wrinkles, acne, and overall skin health. These factors have solidified the segment's position in the global phototherapy equipment market.

Geographical Analysis

North America is expected to hold a significant position in the global phototherapy equipment market share

North America holds a substantial position in the global phototherapy equipment market and is expected to hold most of the market share. The rising incidence of skin diseases, including psoriasis, eczema, and vitiligo, is a major driver for the phototherapy equipment market in North America. As more individuals seek effective treatment options for these conditions, the demand for advanced phototherapy solutions continues to grow. Increased awareness and improved diagnosis of these disorders contribute to higher treatment rates, further boosting market demand.

Neonatal jaundice is a common condition among newborns that leads to increased demand for phototherapy devices specifically designed to manage this issue. Phototherapy has become a standard treatment option in hospitals and clinics across the region due to its effectiveness in reducing bilirubin levels in infants. The consistent need for these treatments ensures a steady market for phototherapy equipment.

Technological innovations in phototherapy equipment, particularly the development of LED-based systems, have significantly improved treatment efficacy and safety. These advancements include features such as remote monitoring and adjustable light intensity, which enhance patient care and convenience. As healthcare providers increasingly adopt these advanced technologies, the market for phototherapy equipment expands.

Furthermore, in this region, a major number of key players present, well-advanced healthcare infrastructure, and innovative product launches that would drive this global phototherapy equipment market growth. For instance, in June 2023, GlobalMed Technologies (GMT) unveiled a new line of topical skincare products designed to enhance the effectiveness of its clinically proven LED light therapy treatments, specifically the Omnilux Contour Face and Omnilux Men. This launch highlights GMT's dedication to innovation in the field of aesthetic dermatology. Thus, the above factors are consolidating the region's position as a dominant force in the global phototherapy equipment market.

Asia Pacific is growing at the fastest pace in the global phototherapy equipment market share

Asia Pacific holds the fastest pace in the global phototherapy equipment market and is expected to hold most of the market share. The increasing prevalence of skin conditions such as psoriasis and eczema are a significant catalyst for the phototherapy equipment market in Asia-Pacific. Growing awareness of these disorders has led more individuals to seek effective treatment options, thereby boosting demand for advanced phototherapy solutions.

Neonatal jaundice remains a common condition among newborns, leading to heightened demand for specialized phototherapy devices. The effectiveness of phototherapy in lowering bilirubin levels has made it a standard treatment in hospitals and clinics throughout the region. The growing geriatric demographic in countries like Japan and South Korea is contributing to the demand for phototherapy devices. Older adults are more susceptible to skin conditions requiring treatment, creating a significant market opportunity for manufacturers.

Innovations in technology, particularly the emergence of LED-based systems, have notably improved the efficacy and safety of phototherapy devices. Features such as remote monitoring and adjustable light intensity enhance patient care and convenience, further encouraging the adoption of these advanced technologies.

Furthermore, key players in the industry initiatives and government-supportive activities would drive this global phototherapy equipment market growth. For instance, in October 2024, the recent inauguration of new healthcare facilities at the All-India Institute of Medical Sciences (AIIMS)-Patna, including the expansion of its neonatal intensive care unit (NICU) from eight to 24 beds, highlights the increasing demand for advanced healthcare solutions.

This demand is particularly evident in the phototherapy equipment market, which is experiencing substantial growth due to rising cases of neonatal jaundice and skin disorders that phototherapy effectively addresses. Thus, the above factors are consolidating the region's position as the fastest-growing force in the global phototherapy equipment market.

Competitive Landscape

The major global players in the phototherapy equipment market include GE Healthcare, Philips, Natus Medical Incorporated, Phoenix Medical Systems., Atom Medical Corp., Nice Neotech Medical Systems Pvt. Ltd., NatBio., Solarc Systems Inc., The Daavlin Company, and MTTS. among others.

Key Developments

  • In March 2024, Celluma Light Therapy unveiled the Celluma CONTOUR, an innovative body contouring device that has gained significant attention for being the first LED light therapy system to receive FDA clearance for over-the-counter body contouring. This milestone represents a major advancement in non-invasive aesthetic treatments, offering consumers an effective and accessible option for body sculpting.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global phototherapy equipment market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Radiation Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovations in Phototherapy Technology
    • 4.1.2. Restraints
      • 4.1.2.1. Risk Factors Associated with the Treatment
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Conventional Phototherapy Equipment*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Full-body Phototherapy Equipment
    • 6.2.4. Partial-body Phototherapy Equipment
    • 6.2.5. Conventional Phototherapy Equipment with Fluorescent Lamp
    • 6.2.6. Conventional Phototherapy Equipment with Compact Fluorescent Lamp
  • 6.3. LED Phototherapy Equipment
  • 6.4. Fiberoptic Phototherapy Equipment
  • 6.5. Germicidal Lamps
  • 6.6. Accessories

7. By Radiation Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Radiation Type
    • 7.1.2. Market Attractiveness Index, By Radiation Type
  • 7.2. UVA (Ultraviolet A*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. UVB (Ultraviolet B)
  • 7.4. UVC (Ultraviolet C)

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Skin Disease Treatment*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 8.2.3. Psoriasis
    • 8.2.4. Eczema
    • 8.2.5. Vitiligo
    • 8.2.6. Acne
    • 8.2.7. Others
  • 8.3. Neonatal Jaundice Management

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals & Specialty Clinics*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Dermatology Centers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Radiation Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Radiation Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Radiation Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Radiation Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Radiation Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. GE Healthcare*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue's
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals etc.
    • 12.1.5. SWOT Analysis
  • 12.2. Philips
  • 12.3. Natus Medical Incorporated
  • 12.4. Phoenix Medical Systems.
  • 12.5. Atom Medical Corp.
  • 12.6. Nice Neotech Medical Systems Pvt. Ltd.
  • 12.7. NatBio.
  • 12.8. Solarc Systems Inc.
  • 12.9. The Daavlin Company
  • 12.10. MTTS.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us